Momentum Stocks: Medifast Inc. (NYSE:MED), Ambev S.A. (NYSE:ABEV), Yingli Green Energy (NYSE:YGE), Meridian Bioscience, Inc. (NASDAQ:VIVO), Fomento Economico Mexicano SAB (ADR) (NYSE:FMX)

Medifast Inc. (NYSE:MED) on Wednesday reported second-quarter profit of $6.2 million. On a per-share basis, the Owings Mills, Maryland-based company said it had profit of 51 cents. Earnings, adjusted to account for discontinued operations, were 48 cents per share. The weight-loss company posted revenue of $72.2 million in the period. Medifast Inc. (NYSE:MED) belongs to Services sector. Its net profit margin is 8.30% and weekly performance is -9.07%. On last trading day company shares ended up $27.87. Medifast Inc. (NYSE:MED) distance from 50-day simple moving average (SMA50) is -12.06%.

On 3 August, Ambev S.A. (NYSE:ABEV) announced its results for the 2015 Q2. The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial Reporting Standards (IFRS), and should be read together with our quarterly financial information for the six-month period ended June 30, 2015 filed with the CVM and submitted to the SEC. Ambev S.A. (NYSE:ABEV) shares decreased -2.28% in last trading session and ended the day at $5.57. Ambev S.A. (NYSE:ABEV) quarterly performance is -14.04%.

Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) said that it has sold a solar power plant located in Essex, United Kingdom. The 18.8 MW facility has been purchased by specialist investment company NextEnergy Solar Fund. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) shares advanced 7.31% in last trading session and ended the day at $0.84. YGE Gross Margin is 16.90% and its return on assets is -4.80%. Yingli Green Energy Holding Co. Ltd. (NYSE:YGE) quarterly performance is -49.88%.

Stock analysts at Canaccord Genuity cut their price objective on shares of Meridian Bioscience (NASDAQ:VIVO) from $20.00 to $19.00 in a report. The firm currently has a “hold” rating on the stock. Meridian Bioscience, Inc. (NASDAQ:VIVO) ended the last trading day at $18.27. Company weekly volatility is calculated as 1.98% and price to cash ratio as 17.85. Meridian Bioscience, Inc. (NASDAQ:VIVO) showed a weekly performance of 0.50%.

Fomento Economico Mexicano, S.A.B de C.V (NYSE:FMX) declared on 23 July, its operational and financial results for the second quarter of 2015. FEMSA consolidated total revenues raised 5.9% and income from operations grew 4.7% compared to the second quarter of 2014, driven by solid growth at FEMSA Comercio. Fomento Economico Mexicano SAB (ADR) (NYSE:FMX) shares advanced 0.23% in last trading session and ended the day at $91.07. FMX Gross Margin is 40.50% and its return on assets is 4.90%. Fomento Economico Mexicano SAB (ADR) (NYSE:FMX) quarterly performance is -2.57%.

Leave a Reply

Your email address will not be published. Required fields are marked *